Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Obesity (Silver Spring). 2021 Jul;29(7):1215–1222. doi: 10.1002/oby.23181

Table 2.

Odds ratios (95% confidence intervals) of prevalent obesity (BMI≥30 kg/m2) at baseline according to quartiles of NT-proBNP at baseline, N=9,681

NT-proBNP categories (pg/mL)
Q1
(≤ 27.17)
Q2
(27.19 – 50.79)
Q3
(50.81 – 90.58)
Q4
(≥ 90.63)
Model 1 1.37 (1.18-1.58)* 1.26 (1.10-1.45)* 1.05 (0.91—1.21) 1 (reference)
Model 2 1.25 (1.08-1.45)* 1.17 (1.02-1.35)* 1.03 (0.89 – 1.18) 1 (reference)

Model 1: Adjusted for age, sex, race-center, smoking status, eGFR, hypertension, diabetes, heart failure, ASCVD (coronary heart disease or stroke). Model 2: Model 1 plus total cholesterol, HDL-cholesterol and lipid lowering medication.

*

p<0.05

ASCVD= atherosclerotic cardiovascular disease; eGFR=Estimated glomerular filtration rate; HDL=High-density lipoprotein